CGEM Q1 2022 Earnings — Cullinan Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

CGEMCullinan Therapeutics, Inc.

$894M

Q1 2022 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$33M

Net Income

-$12M

EPS (Diluted)

$-0.27

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$22M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$437M

Total Liabilities

$18M

Stockholders' Equity

$419M

Cash & Equivalents

$76M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$19M	-100.0%
Gross Profit	$0	$19M	-100.0%
Operating Income	-$33M	$1M	-2480.2%
Net Income	-$12M	-$70,000	-17182.9%